Companies: 10,795·Total market cap: $144.5T
ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc.

NDRANASDAQHealthcare● Active
$4.71
+$0.48(+11.35%)
Market Cap$3544892
P/E Ratio
52W High$11.96
52W Low$2.96
Overview

ENDRA Life Sciences Inc. (NDRA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NDRA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-8.16ndra eps ttm · ndra earnings per shareEarnings history
PE Ratio (TTM)ndra pe ratio ttm · ndra price to earningsPE Ratio deep dive
Revenue (TTM)0.00ndra revenue ttm · ndra annual revenueFull revenue history
Dividend YieldNo Dividenddoes ndra pay dividends · ndra dividend yieldDividend history
Shares Outstanding787,020ndra shares outstanding · ndra floatShares outstanding history
Next EarningsAug 13, 2026Est.ndra earnings date · ndra next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
endra life sciences inc. revenue · ndra revenue 2025
FY 2025Net Income-$7.0M▲ +38.93% YoY
202320242025
endra life sciences inc. net income · ndra profit 2025
FY 2025EPS$-8.93▲ +12.88% YoY
202320242025
ndra eps · endra life sciences inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$7.3MEPS: $-8.16View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis ndra a buy · ndra analyst rating
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$4.71Current
$Avg Target
$High
ndra price target · ndra 12 month forecast

Total: 4 · Buy rate: 100.0%

Stock Performance

Full History
1D+0.24%
1W-18.46%
1M-14.34%
3M+26.19%
YTD-6.40%
1Y+20.80%
5Y-99.99%

About ENDRA Life Sciences Inc.

CEOAlexander Y. Tokman
IPO DateJun 30, 2017
Employees21
CountryUS

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound …

what is endra life sciences inc. · ndra stock overview · endra life sciences inc. company profile · who is endra life sciences inc. ceo · ndra NASDAQ · endra life sciences inc. headquarters · endra life sciences inc. business segments

About Stock Overview & Key Data

ENDRA Life Sciences Inc. (NDRA) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jun 30, 2017. As of the latest trading session, NDRA stock price is $4.71, with a market capitalization of $3.2M. The stock has returned +20.80% over the past 12 months and -6.40% year-to-date.

According to 4 Wall Street analysts, the consensus rating for ENDRA Life Sciences Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, ENDRA Life Sciences Inc. reported revenue of — and net income of -$7.0M. For detailed data — including ENDRA Life Sciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, ENDRA Life Sciences Inc. (NDRA) stock price is $4.71. The stock is traded on NASDAQ under the ticker symbol NDRA. The 52-week range is $2.96 – $11.96.

NDRA stock priceNDRA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice